We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Aquestive Therapeutics
AQST
$553M
| $6.27M | 0.01% |
+970,939
| New | +$6.05M |
|
1227
Alexandria Real Estate Equities
ARE
$8.28B
| $6.26M | 0.01% |
+127,913
| New | +$7.53M |
|
1228
PUT
Synopsys
SNPS
$78.7B
| $6.25M | 0.01% |
13,300
-16,000
| -55% | -$7.11M |
|
1229
PUT
Suncor Energy
SU
$74B
| $6.23M | 0.01% |
140,500
+104,500
| +290% | +$4.42M |
|
1230
Immatics
IMTX
$1.33B
| $6.22M | 0.01% |
+592,428
| New | +$5.98M |
|
1231
Duolingo
DUOL
$6.34B
| $6.21M | 0.01% |
35,392
-379,876
| -91% | -$89.5M |
|
1232
CALL
Gilead Sciences
GILD
$168B
| $6.21M | 0.01% |
50,600
-2,100
| -4% | -$255K |
|
1233
Qualcomm
QCOM
$171B
| $6.2M | 0.01% |
36,267
-10,465
| -22% | -$1.79M |
|
1234
U-Haul Holding Co Series N
UHAL.B
$12.5B
| $6.2M | 0.01% |
132,582
-94,984
| -42% | -$4.62M |
|
1235
CALL
BP
BP
$111B
| $6.19M | 0.01% |
+178,200
| New | +$6.25M |
|
1236
F5
FFIV
$23.4B
| $6.09M | 0.01% |
23,847
+15,038
| +171% | +$4.05M |
|
1237
CALL
Baidu
BIDU
$35.9B
| $6.08M | 0.01% |
46,500
-14,900
| -24% | -$1.85M |
|
1238
Simmons First National
SFNC
$3.42B
| $6.07M | 0.01% |
321,889
+60,243
| +23% | +$1.12M |
|
1239
RTX Corp
RTX
$302B
| $6.05M | 0.01% |
32,986
+26,229
| +388% | +$4.56M |
|
1240
CALL
Salesforce
CRM
$162B
| $6.04M | 0.01% |
22,800
-5,000
| -18% | -$1.24M |
|
1241
Ventas
VTR
$44.6B
| $6.03M | 0.01% |
77,966
+25,388
| +48% | +$1.92M |
|
|
CHYM
1242
Chime Financial
CHYM
$12B
| $6.02M | 0.01% |
+239,244
| New | +$5.08M |
|
|
PONY
1243
Pony AI Inc
PONY
$3.68B
| $6.01M | 0.01% |
414,819
+157,594
| +61% | +$2.62M |
|
1244
PUT
Northern Oil and Gas
NOG
$2.58B
| $6.01M | 0.01% |
+280,000
| New | +$6.28M |
|
1245
CALL
Teva Pharmaceuticals
TEVA
$42.5B
| $6.01M | 0.01% |
192,600
+135,400
| +237% | +$3.34M |
|
1246
Ryan Specialty Holdings
RYAN
$10.8B
| $6.01M | 0.01% |
+116,423
| New | +$6.39M |
|
1247
FIVE9
FIVN
$2.44B
| $5.99M | 0.01% |
298,537
-354,300
| -54% | -$7.52M |
|
1248
PennyMac Financial
PFSI
$3.98B
| $5.98M | 0.01% |
+45,391
| New | +$5.78M |
|
1249
Philip Morris
PM
$290B
| $5.98M | 0.01% |
37,272
+11,702
| +46% | +$1.81M |
|
1250
CALL
Alcoa
AA
$14.3B
| $5.96M | 0.01% |
112,200
+1,100
| +1% | +$45K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.